These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28376164)

  • 1. Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer.
    Briollais L; Ozcelik H; Xu J; Kwiatkowski M; Lalonde E; Sendorek DH; Fleshner NE; Recker F; Kuk C; Olkhov-Mitsel E; Savas S; Hanna S; Juvet T; Hunter GA; Friedlander M; Li H; Chadwick K; Prassas I; Soosaipillai A; Randazzo M; Trachtenberg J; Toi A; Shiah YJ; Fraser M; van der Kwast T; Bristow RG; Bapat B; Diamandis EP; Boutros PC; Zlotta AR
    J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 28376164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts.
    Seibert TM; Fan CC; Wang Y; Zuber V; Karunamuni R; Parsons JK; Eeles RA; Easton DF; Kote-Jarai Z; Al Olama AA; Garcia SB; Muir K; Grönberg H; Wiklund F; Aly M; Schleutker J; Sipeky C; Tammela TL; Nordestgaard BG; Nielsen SF; Weischer M; Bisbjerg R; Røder MA; Iversen P; Key TJ; Travis RC; Neal DE; Donovan JL; Hamdy FC; Pharoah P; Pashayan N; Khaw KT; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Wokolorczyk D; Kluzniak W; Cannon-Albright L; Brenner H; Cuk K; Saum KU; Park JY; Sellers TA; Slavov C; Kaneva R; Mitev V; Batra J; Clements JA; Spurdle A; Teixeira MR; Paulo P; Maia S; Pandha H; Michael A; Kierzek A; Karow DS; Mills IG; Andreassen OA; Dale AM;
    BMJ; 2018 Jan; 360():j5757. PubMed ID: 29321194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate genetic score (PGS-33) is independently associated with risk of prostate cancer in the PLCO trial.
    Liss MA; Xu J; Chen H; Kader AK
    Prostate; 2015 Sep; 75(12):1322-8. PubMed ID: 25982801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline DNA Repair Gene Mutations in Young-onset Prostate Cancer Cases in the UK: Evidence for a More Extensive Genetic Panel.
    Leongamornlert DA; Saunders EJ; Wakerell S; Whitmore I; Dadaev T; Cieza-Borrella C; Benafif S; Brook MN; Donovan JL; Hamdy FC; Neal DE; Muir K; Govindasami K; Conti DV; Kote-Jarai Z; Eeles RA
    Eur Urol; 2019 Sep; 76(3):329-337. PubMed ID: 30777372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Prostinogen (KLK15) genetic variants and prostate cancer risk and aggressiveness in Australia and a meta-analysis of GWAS data.
    Batra J; Lose F; O'Mara T; Marquart L; Stephens C; Alexander K; Srinivasan S; Eeles RA; Easton DF; Al Olama AA; Kote-Jarai Z; Guy M; Muir K; Lophatananon A; Rahman AA; Neal DE; Hamdy FC; Donovan JL; Chambers S; Gardiner RA; Aitken J; Yaxley J; Kedda MA; Clements JA; Spurdle AB
    PLoS One; 2011; 6(11):e26527. PubMed ID: 22132073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival.
    Cao Y; Lindström S; Schumacher F; Stevens VL; Albanes D; Berndt S; Boeing H; Bueno-de-Mesquita HB; Canzian F; Chamosa S; Chanock SJ; Diver WR; Gapstur SM; Gaziano JM; Giovannucci EL; Haiman CA; Henderson B; Johansson M; Le Marchand L; Palli D; Rosner B; Siddiq A; Stampfer M; Stram DO; Tamimi R; Travis RC; Trichopoulos D; Willett WC; Yeager M; Kraft P; Hsing AW; Pollak M; Lin X; Ma J
    J Natl Cancer Inst; 2014 Jun; 106(6):dju085. PubMed ID: 24824313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants in epithelial-mesenchymal transition genes as predictors of clinical outcomes in localized prostate cancer.
    Deng Y; Xie K; Logothetis CJ; Thompson TC; Kim J; Huang M; Chang DW; Gu J; Wu X; Ye Y
    Carcinogenesis; 2020 Aug; 41(8):1057-1064. PubMed ID: 32215555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline mutations in PPFIBP2 are associated with lethal prostate cancer.
    Wu Y; Yu H; Zheng SL; Feng B; Kapron AL; Na R; Boyle JL; Shah S; Shi Z; Ewing CM; Wiley KE; Luo J; Walsh PC; Carter HB; Helfand BT; Cooney KA; Xu J; Isaacs WB
    Prostate; 2018 Dec; 78(16):1222-1228. PubMed ID: 30043417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels.
    Parikh H; Wang Z; Pettigrew KA; Jia J; Daugherty S; Yeager M; Jacobs KB; Hutchinson A; Burdett L; Cullen M; Qi L; Boland J; Collins I; Albert TJ; Vatten LJ; Hveem K; Njølstad I; Cancel-Tassin G; Cussenot O; Valeri A; Virtamo J; Thun MJ; Feigelson HS; Diver WR; Chatterjee N; Thomas G; Albanes D; Chanock SJ; Hunter DJ; Hoover R; Hayes RB; Berndt SI; Sampson J; Amundadottir L
    Hum Genet; 2011 Jun; 129(6):675-85. PubMed ID: 21318478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common variation in Kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressiveness.
    Lose F; Batra J; O'Mara T; Fahey P; Marquart L; Eeles RA; Easton DF; Al Olama AA; Kote-Jarai Z; Guy M; Muir K; Lophatananon A; Rahman AA; Neal DE; Hamdy FC; Donovan JL; Chambers S; Gardiner RA; Aitken JF; Yaxley J; Alexander K; Clements JA; Spurdle AB; Kedda MA;
    Urol Oncol; 2013 Jul; 31(5):635-43. PubMed ID: 21741862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between cytochrome CYP17A1, CYP3A4, and CYP3A43 polymorphisms and prostate cancer risk and aggressiveness in a Korean study population.
    Han JH; Lee YS; Kim HJ; Lee SY; Myung SC
    Asian J Androl; 2015; 17(2):285-91. PubMed ID: 25337833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of 8 loci on chromosome 8q24 with prostate carcinoma risk in northern Chinese men.
    Zhao CX; Liu M; Wang JY; Xu Y; Wei D; Yang K; Yang Z
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6733-8. PubMed ID: 24377597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyzing the Association of Polymorphisms in the CRYBB2 Gene with Prostate Cancer Risk in African Americans.
    Faruque MU; Paul R; Ricks-Santi L; Jingwi EY; Ahaghotu CA; Dunston GM
    Anticancer Res; 2015 May; 35(5):2565-70. PubMed ID: 25964531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF polymorphisms and prostate cancer risk.
    Danforth KN; Rodriguez C; Hayes RB; Sakoda LC; Huang WY; Yu K; Calle EE; Jacobs EJ; Chen BE; Andriole GL; Figueroa JD; Yeager M; Platz EA; Michaud DS; Chanock SJ; Thun MJ; Hsing AW
    Prostate; 2008 Mar; 68(4):400-7. PubMed ID: 18196539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction among apoptosis-associated sequence variants and joint effects on aggressive prostate cancer.
    Lavender NA; Rogers EN; Yeyeodu S; Rudd J; Hu T; Zhang J; Brock GN; Kimbro KS; Moore JH; Hein DW; Kidd LC
    BMC Med Genomics; 2012 Apr; 5():11. PubMed ID: 22546513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort.
    Srivastava P; Kapoor R; Mittal RD
    Gene; 2013 Nov; 530(2):273-7. PubMed ID: 23872201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kallikrein 3 and vitamin D receptor polymorphisms: potentials environmental risk factors for prostate cancer.
    Hu J; Qiu Z; Zhang L; Cui F
    Diagn Pathol; 2014 Apr; 9():84. PubMed ID: 24755043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of HNF1B, KLK3, ELAC2, TMPRSS2-ERG, and CTNNB1 polymorphisms associated with prostate cancer in samples of patients from HUPE-UERJ.
    Menezes RDS; Dornas MC; Campos CFF; Rodeiro DB; Carrerette FB; Oliveira RV; de Souza BA; Alves de Souza Carvalho G; Brito IAA; Silva DA; Damião R; Porto LC
    Prostate; 2024 Feb; 84(2):166-176. PubMed ID: 37839045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants in the TEP1 gene are associated with prostate cancer risk and recurrence.
    Gu C; Li Q; Zhu Y; Qu Y; Zhang G; Wang M; Yang Y; Wang J; Jin L; Wei Q; Ye D
    Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):310-6. PubMed ID: 26238235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic predisposition to early recurrence in clinically localized prostate cancer.
    Borque Á; del Amo J; Esteban LM; Ars E; Hernández C; Planas J; Arruza A; Llarena R; Palou J; Herranz F; Raventós CX; Tejedor D; Artieda M; Simon L; Martínez A; Carceller E; Suárez M; Allué M; Sanz G; Morote J
    BJU Int; 2013 Apr; 111(4):549-58. PubMed ID: 22759231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.